Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
InnoCare Pharma RMB2.9 billion Shanghai IPO
This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
Nayax direct listing
The shares are listed on the Nasdaq Global Select Market
Tencent Music Entertainment Group secondary listing
We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
Toyota Motor Credit $2.25 billion notes offering
We advised the company on the SEC-registered notes offering
Allakos $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Medtronic Global Holdings €3.5 billion notes offering
The investment-grade notes were issued in four tranches
Alignment Healthcare $132.75 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
Home Depot $3 billion notes offering
The investment-grade notes are due 2025, 2032 and 2052
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market